Literature DB >> 35086372

Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy.

Elif Gokcal1, Mitchell J Horn1, J Alex Becker2, Alvin S Das1, Kristin Schwab1, Alessandro Biffi1, Natalia Rost1, Jonathan Rosand1, Anand Viswanathan1, Jonathan R Polimeni3, Keith A Johnson2, Steven M Greenberg1, M Edip Gurol1.   

Abstract

We postulated that vascular dysfunction mediates the relationship between amyloid load and white matter hyperintensities (WMH) in cerebral amyloid angiopathy (CAA). Thirty-eight cognitively healthy patients with CAA (mean age 70 ± 7.1) were evaluated. WMH was quantified and expressed as percent of total intracranial volume (pWMH) using structural MRI. Mean global cortical Distribution Volume Ratio representing Pittsburgh Compound B (PiB) uptake (PiB-DVR) was calculated from PET scans. Time-to-peak [TTP] of blood oxygen level-dependent response to visual stimulation was used as an fMRI measure of vascular dysfunction. Higher PiB-DVR correlated with prolonged TTP (r = 0.373, p = 0.021) and higher pWMH (r = 0.337, p = 0.039). Prolonged TTP also correlated with higher pWMH (r = 0.485, p = 0.002). In a multivariate linear regression model, TTP remained independently associated with pWMH (p = 0.006) while PiB-DVR did not (p = 0.225). In a bootstrapping model, TTP had a significant indirect effect (ab = 0.97, 95% CI: 0.137-2.461), supporting that the association between PiB-DVR and pWMH is mediated by TTP response. There was no longer a direct effect independent of the hypothesized pathway. Our study suggests that the effect of vascular amyloid load on white matter disease is mediated by vascular dysfunction in CAA. Amyloid lowering strategies might prevent pathophysiological processes leading to vascular dysfunction, therefore limiting ischemic brain injury.

Entities:  

Keywords:  Amyloid angiopathy; cerebral autoregulation; cerebrovascular disease; molecular imaging; positron emission tomography; white matter disease

Mesh:

Substances:

Year:  2022        PMID: 35086372      PMCID: PMC9207495          DOI: 10.1177/0271678X221076571

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.960


  40 in total

Review 1.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease.

Authors:  Marco Pasi; Gregoire Boulouis; Panagiotis Fotiadis; Eitan Auriel; Andreas Charidimou; Kellen Haley; Alison Ayres; Kristin M Schwab; Joshua N Goldstein; Jonathan Rosand; Anand Viswanathan; Leonardo Pantoni; Steven M Greenberg; M Edip Gurol
Journal:  Neurology       Date:  2017-05-05       Impact factor: 9.910

3.  White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage.

Authors:  E E Smith; M E Gurol; J A Eng; C R Engel; T N Nguyen; J Rosand; S M Greenberg
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

4.  Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy.

Authors:  M Edip Gurol; Gregory Dierksen; Rebecca Betensky; Christopher Gidicsin; Amy Halpin; Alex Becker; Jeremy Carmasin; Alison Ayres; Kristin Schwab; Anand Viswanathan; David Salat; Jonathan Rosand; Keith A Johnson; Steven M Greenberg
Journal:  Neurology       Date:  2012-07-11       Impact factor: 9.910

5.  Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.

Authors:  Panagiotis Fotiadis; Sanneke van Rooden; Jeroen van der Grond; Aaron Schultz; Sergi Martinez-Ramirez; Eitan Auriel; Yael Reijmer; Anna M van Opstal; Alison Ayres; Kristin M Schwab; Trey Hedden; Jonathan Rosand; Anand Viswanathan; Marieke Wermer; Gisela Terwindt; Reisa A Sperling; Jonathan R Polimeni; Keith A Johnson; Mark A van Buchem; Steven M Greenberg; M Edip Gurol
Journal:  Lancet Neurol       Date:  2016-05-11       Impact factor: 44.182

6.  Distribution of Lacunar Infarcts in Asians With Intracerebral Hemorrhage: A Magnetic Resonance Imaging and Amyloid Positron Emission Tomography Study.

Authors:  Hsin-Hsi Tsai; Marco Pasi; Li-Kai Tsai; Ya-Fang Chen; Bo-Ching Lee; Sung-Chun Tang; Panagiotis Fotiadis; Chen-Yu Huang; Ruoh-Fang Yen; M Edip Gurol; Jiann-Shing Jeng
Journal:  Stroke       Date:  2018-04-25       Impact factor: 7.914

7.  Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.

Authors:  Steven M Greenberg; Thomas Grabowski; M Edip Gurol; Maureen E Skehan; R N Kaveer Nandigam; John A Becker; Monica Garcia-Alloza; Claudia Prada; Matthew P Frosch; Jonathan Rosand; Anand Viswanathan; Eric E Smith; Keith A Johnson
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

8.  Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.

Authors:  Li Xiong; Gregoire Boulouis; Andreas Charidimou; Duangnapa Roongpiboonsopit; Michael J Jessel; Marco Pasi; Yael D Reijmer; Panagiotis Fotiadis; Alison Ayres; Emily Merrill; Kristin Schwab; Deborah Blacker; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-20       Impact factor: 6.960

9.  Immunotherapy with ponezumab for probable cerebral amyloid angiopathy.

Authors:  Claire Leurent; James A Goodman; Yao Zhang; Ping He; Jonathan R Polimeni; Mahmut Edip Gurol; Monica Lindsay; Linda Frattura; Usharbudh Shivraj Sohur; Anand Viswanathan; Martin M Bednar; Eric E Smith; Steven M Greenberg
Journal:  Ann Clin Transl Neurol       Date:  2019-03-18       Impact factor: 4.511

10.  Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.

Authors:  M Edip Gurol; J Alex Becker; Panagiotis Fotiadis; Grace Riley; Kristin Schwab; Keith A Johnson; Steven M Greenberg
Journal:  Neurology       Date:  2016-09-07       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.